News

Compass Therapeutics to Reveal Financial Insights on Q2 Performance

Compass Therapeutics to Reveal Financial Insights on Q2 Performance

Upcoming Financial Results and Business Update

Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company focusing on oncology, is slated to announce its financial results for the second quarter. This announcement coincides with a conference call that will provide insights into their current research efforts. The event is scheduled for Monday, August 11, and will begin at 8:00 a.m. ET.

Details of the Event

During this virtual event, Compass Therapeutics will not only discuss financial results but also share updates on pivotal projects. This includes ongoing development for tovecimig, a Phase 2/3 clinical study, along with essential data regarding CTX-8371 and CTX-10726. Investors and interested parties can anticipate a thorough review of the company’s progress.

Call Information

The call will open on August 11, 2025, at 8:00 AM ET. Participants can join via a telephone dial-in featuring two options: 1-877-407-9716 for US callers and 1-201-493-6779 for international participants. The conference ID for the call is 13754954, making it easy for individuals to connect.

Webcast Availability

A live webcast of the event will be hosted and will also be accessible for replay. This means stakeholders will have the opportunity to revisit the discussions for a limited time following the event.

Company Overview

Compass Therapeutics is committed to innovating in the field of oncology through the development of antibody-based therapeutics aimed at various diseases. Their strategic focus lies in understanding the interaction between angiogenesis, the immune system, and tumor development. The company has established a diverse pipeline of product candidates, each designed to effectively engage with critical biological pathways needed for an anti-tumor response.

Innovative Research Approach

By capitalizing on its strong foundation in scientific research, Compass aims to craft targeted therapies that include agents for angiogenesis, immune response activators, and strategies to counteract the immunosuppressive tactics used by tumors. These efforts reflect Compass Therapeutics’ commitment to clinical development that emphasizes both standalone and combinatorial therapies utilizing their proprietary pipeline antibodies.

Investor Relations

For those interested in investor relations, further inquiries can be directed to the Investor contact via email at ir@compasstherapeutics.com. Media inquiries can be made to Anna Gifford, Chief of Staff, at media@compasstherapeutics.com or by phone at 617-500-8099.

Frequently Asked Questions

What is the date of Compass Therapeutics' financial results announcement?

The financial results will be announced on August 11, 2025.

How can I participate in the conference call?

You can join the conference call by dialing 1-877-407-9716 for US participants or 1-201-493-6779 for international participants. Use conference ID 13754954.

Will there be a webcast available?

Yes, there will be a live webcast available along with a replay for a limited time post-event.

What is the main focus of Compass Therapeutics?

Compass Therapeutics focuses on developing proprietary antibody-based therapeutics for oncology, targeting multiple critical pathways relevant for treating tumors.

Who can I contact for investor relations?

For investor relations inquiries, please email ir@compasstherapeutics.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ACME's AI Innovation Shakes Up Filmmaking Scene

Updated Category News Views 87

The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...

Continue Reading
Choosing Expert European Auto Repair: Key Insights

Updated Category News Views 127

The Perks of Specialist Knowledge Ever get the feeling your local auto shop doesn't always cut it when your sleek BMW or classy Mercedes needs a tweak? You're not alone. Specifically, for those driving around Alpharetta, European vehicles demand not just routine check-ups but specialist hands. Much like how you wouldn't hand your luxury timepiece to the shop down the...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Matthew Callstrom Named CEO: Mayo Clinic's Next Era

Updated Category News Views 215

Leadership Change at Mayo Clinic: A Turning Point The Mayo Clinic, a titan in healthcare lands, is on the cusp of a major leadership switch-up. As the trustees hand the reins to Dr. Matthew R. Callstrom, they're banking on a rich blend of experience and visionary thinking to steer their ship. We're looking at what this change might spell for Mayo's storied mission. Who is...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Backdoor Reference Checks: A Hiring Minefield?

Updated Category News Views 181

What's Really Happening with Job References? Every job seeker has been there, right? You're all set, resume polished to a shine, references lined up like a choir ready to sing your praises, and then bam—you hear that employers are contacting folks you never listed. A new report from Zety highlights this eyebrow-raising trend, and it's got us all questioning the value...

Continue Reading
Foreigner to Rock Irvine with Night Ranger in 2027

Updated Category News Views 85

Irvine Set for a Rock Revival Talk about a blast from the past! On March 27, 2027, two titans of the rock world, Foreigner and Night Ranger, are set to ignite Irvine like it's the glory days of arena rock all over again. Hosted at the Great Park Live, this show isn't just a concert—it's a full-scale invasion of rock's golden age right into Southern California's heart....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 54

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

LLCP Promotions: A Positive Spin or a Prelude to Trouble?

Updated Category News Views 211

Levine Leichtman Capital Partners (LLCP) just gave its Finance and Administration team a shake-up with promotions announced on February 17, 2026. Sure, the firm hails from Los Angeles—where they like to keep things sunny—but these moves might be less about shining futures and more about staving off trouble. Who’s Climbing the LLCP Ladder? Key Players Promoted...

Continue Reading
Understanding Novo Nordisk's Market Sentiment and Trends

Updated Category News Views 187

Novo Nordisk's Current Short Interest Overview Novo Nordisk's short percent of float has decreased substantially, reflecting a 7.89% drop since its last report. The company has disclosed that there are currently 23.58 million shares sold short. This figure corresponds to around 0.7% of all the shares that are available for public trading. Given the trading activity,...

Continue Reading
LG Innotek Launches Innovative Digital Key to Transform Driving

Updated Category News Views 226

Revolutionizing Vehicle Access with Innovative Technology LG Innotek has introduced an exciting new product, the 'Next-generation Digital Key Solution'. This innovative technology connects smartphones to vehicles, allowing users to lock and unlock doors and start engines seamlessly through wireless communication. The digital key’s unique design eliminates the risk of...

Continue Reading
Exciting Opportunities: Auction Details for Office Properties

Updated Category News Views 318

Exciting Opportunities: Auction Details for Office Properties Hilco Real Estate Sales has recently announced an upcoming auction featuring two prominent office buildings designed to capture interest from investors and developers alike. Set in highly visible locations, these properties are prime candidates for a range of investment opportunities. Auction Announcement The...

Continue Reading
Grease Monkey and SpeeDee Oil Change Celebrate Franchise Success

Updated Category News Views 243

Grease Monkey and SpeeDee Oil Change Shine in Franchise Rankings Grease Monkey and SpeeDee Oil Change have recently made headlines after securing their spots in the coveted Franchise Times Top 400 list. This recognition showcases their growth and resilience in the automotive service sector, highlighting the commitment to providing excellent service to their customers. A...

Continue Reading